Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GRAL
LGND
Add up to 3 more stocks
GRAL
GRAIL Inc.
-10.75%
$137.52-16.56Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$5.90B
52W Range
$41.50 - $156.49
LGND
Ligand Pharmaceuticals Incorporated
-2.81%
$298.14-8.63Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$5.98B
52W Range
$175.89 - $326.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 31.89 |
| Forward P/E | N/A | 32.04 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.32 | 6.18 |
| P/S Ratio | 35.71 | 20.57 |
| P/FCF Ratio | N/A | 45.48 |
| EV/EBITDA | N/A | 45.20 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -42.5% | 98.6% |
| Operating Margin | -362.9% | 17.6% |
| Net Margin | -236.9% | 67.9% |
| ROE | -15.4% | 20.4% |
| ROA | -13.8% | 9.0% |
| ROIC | -20.3% | 3.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.95 | 31.18 |
| Quick Ratio | 10.74 | 30.96 |
| Debt/Equity | 0.04 | 1.17 |
| Interest Coverage | N/A | 10.01 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.